JPMorgan raised the firm’s price target on Amicus (FOLD) to $17 from $16 and keeps an Overweight rating on the shares. The firm updated models in the Smid-cap biotechnology space.
Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FOLD: